Literature DB >> 2827040

Loss of constitutional heterozygosity in colon carcinoma from patients with familial polyposis coli.

M Okamoto1, M Sasaki, K Sugio, C Sato, T Iwama, T Ikeuchi, A Tonomura, T Sasazuki, M Miyaki.   

Abstract

Recent studies have suggested a critical role of specific gene loss in several embryonic tumours and certain adult cancers. In retinoblastoma, hemizygosity or homozygosity of a recessive mutant allele results in the loss of normal gene product, and this seems to cause the manifestation of the disorder. Familial polyposis coli (FPC) is a human autosomal dominant trait characterized by numerous adenomatous polyps of the colon and rectum, and a high incidence of colon carcinoma. Karyotype analyses have failed to detect specific deletion or translocation. We report the use of polymorphic DNA markers to look for the somatic loss of heterozygosity at specific loci. Investigation of 38 tumours from 25 FPC patients, and 20 sporadic colon carcinomas from 19 patients, revealed frequent occurrence of allele loss on chromosome 22, with some additional losses on chromosomes 5, 6, 12q and 15. The FPC gene-linked DNA probe C11p11 also detected frequent allele loss in both familial and sporadic colon carcinomas but not in benign adenomas. These results suggest the possible involvement of more than one chromosomal locus in the development of familial and sporadic colon carcinomas.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2827040     DOI: 10.1038/331273a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  33 in total

Review 1.  Genetics of colon cancer.

Authors:  D J Ahnen
Journal:  West J Med       Date:  1991-06

2.  Flanking markers bracket the neurofibromatosis type 2 (NF2) gene on chromosome 22.

Authors:  G A Rouleau; B R Seizinger; W Wertelecki; J L Haines; D W Superneau; R L Martuza; J F Gusella
Journal:  Am J Hum Genet       Date:  1990-02       Impact factor: 11.025

3.  Localization of the genetic defect in familial adenomatous polyposis within a small region of chromosome 5.

Authors:  Y Nakamura; M Lathrop; M Leppert; M Dobbs; J Wasmuth; E Wolff; M Carlson; E Fujimoto; K Krapcho; T Sears
Journal:  Am J Hum Genet       Date:  1988-11       Impact factor: 11.025

4.  Activation of the pp60c-src protein kinase is an early event in colonic carcinogenesis.

Authors:  C A Cartwright; A I Meisler; W Eckhart
Journal:  Proc Natl Acad Sci U S A       Date:  1990-01       Impact factor: 11.205

Review 5.  Development and progression of colorectal neoplasia.

Authors:  Upender Manne; Chandrakumar Shanmugam; Venkat R Katkoori; Harvey L Bumpers; William E Grizzle
Journal:  Cancer Biomark       Date:  2010       Impact factor: 4.388

Review 6.  Genetic alterations in primary breast cancer.

Authors:  R Callahan
Journal:  Breast Cancer Res Treat       Date:  1989-07       Impact factor: 4.872

7.  Telomere shortening of epithelial cells characterises the adenoma-carcinoma transition of human colorectal cancer.

Authors:  R R Plentz; S U Wiemann; P Flemming; P N Meier; S Kubicka; H Kreipe; M P Manns; K L Rudolph
Journal:  Gut       Date:  2003-09       Impact factor: 23.059

Review 8.  Constitutional ring chromosomes and tumour suppressor genes.

Authors:  N Tommerup; R Lothe
Journal:  J Med Genet       Date:  1992-12       Impact factor: 6.318

Review 9.  Risk and surveillance of individuals with heritable factors for colorectal cancer. WHO Collaborating Centre for the Prevention of Colorectal Cancer.

Authors:  R W Burt; D T Bishop; H T Lynch; P Rozen; S J Winawer
Journal:  Bull World Health Organ       Date:  1990       Impact factor: 9.408

10.  Exclusion of the retinoblastoma gene and chromosome 13q as the site of a primary lesion for human breast cancer.

Authors:  A M Bowcock; J M Hall; J M Hebert; M C King
Journal:  Am J Hum Genet       Date:  1990-01       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.